Recent Comments

    • Your corporate and securities law firm

    • Our expertise at your service

    • A team to protect your interests

    • Your goal - our priority


    About Lexelians law firm

    Founded in 2012 by Laurent Beauvoit, LEXELIANS is an independent law firm with a recognised expertise in:

    • Capital markets transactions (IPOs, capital increases, issues of securities …) and tender offers
    • Securities law
    • Corporate law for listed and non-listed companies
    • Private equity
    • M&A
    • Contract law

    LEXELIANS lawyers assist companies – mainly small and mid caps – in their development projects and growth. In a few years, LEXELIANS law firm has become the regular legal advisor of several listed and non listed companies, in France and outside of France, from innovative business sectors (such as new technologies, medtechs, cleantechs, greentech, biotechs, etc) to traditional business industries (healthcare, luxe, design, cinema, etc).

    LEXELIANS lawyers goal is to build long-term relationships with our clients, adapting our legal services to your diverse needs. We apply the rigorous and demanding methods that an activity requires at the highest level of quality, while combining spirit of enterprise, pragmatism and availability.

    For any fields of law outside of its competence or foreign law, LEXELIANS law firm will rely on its network of lawyers built throughout the years.

    With substantial prior experience in leading French and Anglo-Saxon law firms, Laurent Beauvoit has been involved in more than a hundred of financial transactions including IPOs/privatizations (EDF, ConcoursMania, Diaxonhit, Horizontal Software …), capital increases (Société Générale, France Telecom, Veolia Environnement, Rhodia, Diaxonhit …), issues of securities (convertibles, ORNANEs, OCEANEs … by Business Objects, Altran, Publicis …), tender offers (Grand Marnier, Business Objects, Infogrames …) and bond issues (Aurea, Infogrames, Rhodia, CMA-CGM …).

    LEXELIANS law firm received several awards. We were proud to rank for the third time in a row No. 1 in High Reputation of law firms’ Capital Markets Equities and Convertibles – Smid Caps in the magazine Décideurs – Leaders League (January 2017).

    Our Team

    Laurent Beauvoit


    Jonathan Santoro


    Lisa Nyzhnyk


    Lexelians lawyers advise you all along your development

    To provide the best answers to your questions.

    Our Clients

    Awards and Recognitions

    “We have recently been able to work with Laurent on a fundraising transaction for a mid-sized company listed on Alternext. His reactivity and his skills contributed to the success of the deal – as well as his friendliness. It looks like some more collaborations are to come!”

    Simon Derbanne, NFinances

    “I have worked with Laurent and his team on several occasions: IPOs, capital increases, special benefits… It is always a delight to work with such tremendous professionals: available, pragmatic and focused on the clients’ best interests.”

    Benjamin Haziza, Senior Manager, Deloitte & Associés

    “We have been working with Laurent Beauvoit and his team for several years. Beyond their technical skills, we particularly appreciate their great reactivity and availability. We recommend Lexelians law firm, particularly to mid-sized companies involved in capital market transactions”

    Nicolas Déhais, Corporate Finance


    Capital Markets

    2M€ equity funding of Itrust

    February 25, 2019
    Lexelians advises Itrust, the expert in IT security, as part of its 2M€ equity funding. For more

    IPO on Euronext Growth market in Paris

    January 29, 2019
    Lexelians advises Predilife for its IPO on Euronext Growth market in Paris On December 18, 2018, Predilife (Paris : ALPRE), the healthcare actor predicting hazardous diseases, announced its listing on Euronext Growth market in Paris through a public offer amounting to 3.6M€. Lexelians (Laurent

    Equity financing amounting of 3,6M€ of THERACLION

    June 11, 2018
    June 11, 2018, LEXELIANS advises THERACLION (Euronext Growth, FR0010120402), the specialist of medical device dedicated to echotherapy, as part of an equity financing amounting to 3,6M€ to the benefit of NICE & GREEN. For more

    Convertible bonds issue of GECI INTERNATIONAL

    June 11, 2018
    June 11, 2018, Lexelians advises GECI INTERNATIONAL (Euronext : FR0000079634 GECP), the specialist of high-tech engineering, as part of the issue of convertible bonds (ORNANE) with warrants attached amounting to 2M€ to the benefit of Yorkville. For more information,

    Bank financing amounting of 2,8M€ for SEPIMO

    June 8, 2018
    June 8, 2018, LEXELIANS advises SEPIMO, the specialist of real estate development in Ile de France, Normandy and Haute-Savoie, as part of a bank financing amounting to 2.8M€. This financing is aiming at partially refinancing the acquisition of Jean Coeur Promotion in December

    Listing on Euronext Access of PARX PLASTICS

    May 4, 2018
    LEXELIANS advised PARX PLASTICS, the specialist in biocompatible plastics and antibacterial polymers, as part of its listing on Euronext Access on May 4, 2018. The market capitalization of the company on the day of the introduction amounts to € 24.3 million. As part of this operation, the

    Convertible bonds amounting of Group VERGNET

    May 3, 2018
    May 3, 2018, Lexelians advises a private investor as part of the issue of convertible bonds amounting to 1,1M€ by Group VERGNET (Euronext Growth Paris : FR0004155240 – ALVER), a company specialized in providing solutions in renewable energy. For more information

    Listing on Euronext Access

    March 22, 2018
    LEXELIANS advises MEDIALAB, the software expert in the dental industry, in the context of its listing on Euronext Access. For more information: Communiqué de presse

    Private placement

    February 22, 2018
    Lexelians advises Horizontal Software in its private placement of 1.3 M€. For more information: Communiqué de

    Transfer of registered office

    January 1, 2018
    In January 2018, LEXELIANS advises GOUR MEDICAL, the advanced care company for pets, in the context of the transfer of its registered office from Switzerland to France. For more information